MAOB - monoamine oxidase B Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 414909
About MAOB
Primary_assembly X: 39,025,970-39,144,345 reverse strand.Sscrofa11.1:CM000830.5
This gene has 3 transcripts (splice variants), 333 orthologues and 8 paralogues. Biased expression in liver (RPKM 115.4), kidney (RPKM 19.5) and 3 other tissues.
MAOB Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001001864.1 | NP_001001864.1 | amine oxidase [flavin-containing] B |
MAOB Protein Structure
Amino_oxidase
Amino_oxidase: pfam01593 (13 - 450)
- 0
- 100
- 200
- 300
- 400
- 520 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
amine oxidase [flavin-containing] B |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(16)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14199 | Selegiline hydrochloride | Inhibitor | 99.96% | Unkown |
| HY-12723 | Apomorphine | 99.48% | Unkown | |
| HY-14280 | Entacapone | Inhibitor | 99.97% | Yes |
| HY-N0159 | Paeonol | 99.98% | Unkown | |
| HY-B1018A | Phenelzine sulfate | Inhibitor | 99.96% | Unkown |
| HY-A0091A | Pargyline | Inhibitor | 99.92% | Unkown |
| HY-70057 | Safinamide | Inhibitor | 99.86% | Yes |
| HY-A0091 | Pargyline hydrochloride | Inhibitor | 99.91% | Unkown |
| HY-70057A | Safinamide mesylate | Inhibitor | 99.07% | Yes |
| HY-14855B | Tedizolid phosphate | Inhibitor | 99.61% | Yes |
| HY-N0159R | Paeonol (Standard) | 99.98% | Unkown | |
| HY-B1558A | Bifemelane hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-14198 | Selegiline | Inhibitor | / | Unkown |
| HY-14280R | Entacapone (Standard) | Inhibitor | 99.24% | Unkown |
| HY-12723R | Apomorphine (Standard) | / | Unkown | |
| HY-14280A | Entacapone sodium salt | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-103164A | 8-(3-Chlorostyryl)caffeine | / | Phase 4 | |
| HY-N0529 | Rosmarinic acid | 99.73% | Phase 3 | |
| HY-154977 | ETAP | Inhibitor | / | Phase 3 |
| HY-129388B | Pulrodemstat benzenesulfonate | Inhibitor | 99.64% | Phase 2 |
| HY-112623 | Vafidemstat | Inhibitor | 98.03% | Phase 2 |
| HY-129388A | Pulrodemstat | Inhibitor | 98.86% | Phase 2 |
| HY-10400 | Ladostigil hemitartrate | Inhibitor | 98.90% | Phase 2 |
| HY-10399A | Ladostigil hydrochloride | Inhibitor | 99.91% | Phase 2 |
| HY-10399 | Ladostigil | Inhibitor | / | Phase 2 |
| HY-129388 | Pulrodemstat Methylbenzenesulfonate | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(190)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-W008566 | Norharmane | Inhibitor | 99.93% | Unkown |
| HY-N7204 | 4-Hydroxyderricin | 99.79% | Unkown | |
| HY-W015490 | 1,4-Naphthoquinone | Inhibitor | 99.97% | Unkown |
| HY-N0381 | Maackiain | 99.83% | Unkown | |
| HY-110130 | RN-1 dihydrochloride | Inhibitor | 99.21% | Unkown |
| HY-E70074 | Monoamine oxidase, plasma | / | Unkown | |
| HY-103164 | (E)-8-(3-Chlorostyryl)caffeine | 99.4% | Unkown | |
| HY-127109 | Tisolagiline | Inhibitor | 99.85% | Unkown |
| HY-N0026 | 2'-Acetylacteoside | Inhibitor | 99.73% | Unkown |
| HY-19333 | OG-L002 | Inhibitor | 99.55% | Unkown |
| HY-N0918 | Desmethoxyyangonin | 99.00% | Unkown | |
| HY-N9540 | Methyl citrate | Inhibitor | 98.0% | Unkown |
| HY-119532 | Nordeprenyl | 95.13% | Unkown | |
| HY-16677A | Mofegiline hydrochloride | Inhibitor | 99.57% | Unkown |
| HY-114520 | TT01001 | Inhibitor | 99.93% | Unkown |
| HY-127109A | Tisolagiline monomethylsulfate | Inhibitor | 99.83% | Unkown |
| HY-131036 | MAO-IN-M30 dihydrochloride | Inhibitor | 98.48% | Unkown |
| HY-14201 | Lazabemide | Inhibitor | 99.95% | Unkown |
| HY-14203 | (R)-Safinamide | Inhibitor | 99.89% | Unkown |
| HY-D0004 | Azure B | Inhibitor | 99.87% | Unkown |
| HY-100588 | VU0364770 | Agonist | 99.94% | Unkown |
| HY-149213 | LSD1/TLK1-IN-1 | 99.20% | Unkown | |
| HY-117173 | (Rac)-Rasagiline | Inhibitor | ≥97.0% | Unkown |
| HY-W655727 | (-)-2-Phenylpropylamine | Inhibitor | 98.44% | Unkown |
| HY-142026 | Vitisin A | 96% | Unkown | |
| HY-121072 | ASS234 | Inhibitor | 99.6% | Unkown |
| HY-127109B | Tisolagiline methylsulfate | Inhibitor | 99.82% | Unkown |
| HY-W001601 | Budipine | Antagonist | 99.41% | Unkown |
| HY-W015490S | 1,4-Naphthoquinone-d6 | Inhibitor | 99.20% | Unkown |
| HY-W049881 | 9-Methyl-β-carboline | 99.86% | Unkown | |
| HY-101578 | 2614W94 | Inhibitor | 99.76% | Unkown |
| HY-114620 | MAO-B-IN-55 | Inhibitor | 98.10% | Unkown |
| HY-120419 | PF9601N | Inhibitor | 99.85% | Unkown |
| HY-120826 | A2AAR/hMAO-B-IN-1 | Inhibitor | 99.0% | Unkown |
| HY-132907 | MAO-B-IN-2 | Inhibitor | 99.05% | Unkown |
| HY-14280S | Entacapone-d10 | Inhibitor | 98.6% | Unkown |
| HY-146958 | MAO-B-IN-8 | Inhibitor | 98.03% | Unkown |
| HY-156255 | MAO-B-IN-25 | Inhibitor | 99.11% | Unkown |
| HY-70057S1 | Safinamide-d4-1 | Inhibitor | 98.90% | Unkown |
| HY-B1018AS | Phenelzine-d5 sulfate | Inhibitor | 99.97% | Unkown |
| HY-W010130 | 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone | Inhibitor | 99.96% | Unkown |
| HY-W845607 | Milacemide | Inhibitor | 98.04% | Unkown |
| HY-172451 | MC4762 | Inhibitor | / | Unkown |
| HY-100679B | (R)-Pirlindole mesylate | Inhibitor | / | Unkown |
| HY-103477 | MAO-B-IN-51 | Inhibitor | / | Unkown |
| HY-106972 | SL-251131 | Inhibitor | / | Unkown |
| HY-114915 | PSB-1434 | Inhibitor | 98.05% | Unkown |
| HY-115986 | MAO-B-IN-5 | Inhibitor | / | Unkown |
| HY-115987 | MAO-B-IN-6 | Inhibitor | / | Unkown |
| HY-116097 | PSB-1491 | Inhibitor | / | Unkown |
| HY-116765 | MAO-B-IN-35 | / | Unkown | |
| HY-117502 | SL-25.1188 | Inhibitor | / | Unkown |
| HY-123665 | PSB-1410 | Inhibitor | 99.22% | Unkown |
| HY-129388C | Pulrodemstat hydrochloride | Inhibitor | / | Unkown |
| HY-129479 | Almoxatone | Inhibitor | / | Unkown |
| HY-130205 | Milacemide hydrochloride | Inhibitor | / | Unkown |
| HY-131660 | MAO-B-IN-54 | Inhibitor | / | Unkown |
| HY-134664 | 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate | Inhibitor | / | Unkown |
| HY-136878 | LSD1-IN-10 | Inhibitor | / | Unkown |
| HY-14198B | (±)-Selegiline hydrochloride | Inhibitor | / | Unkown |
| HY-14202 | Lazabemide hydrochloride | Inhibitor | 95.0% | Unkown |
| HY-143244 | Monoamine Oxidase B inhibitor 1 | Inhibitor | / | Unkown |
| HY-143245 | Monoamine Oxidase B inhibitor 2 | Inhibitor | / | Unkown |
| HY-143329 | MAO-B-IN-3 | Inhibitor | / | Unkown |
| HY-143330 | MAO-B-IN-4 | Inhibitor | / | Unkown |
| HY-143438 | 2-PAT | Inhibitor | / | Unkown |
| HY-144673 | LSD1-IN-12 | Inhibitor | / | Unkown |
| HY-144756 | LSD1-IN-15 | Inhibitor | / | Unkown |
| HY-144757 | LSD1-IN-16 | Inhibitor | / | Unkown |
| HY-144758 | LSD1-IN-17 | Inhibitor | / | Unkown |
| HY-144824 | Monoamine oxidase/Aromatase-IN-1 | Inhibitor | / | Unkown |
| HY-145845 | HDAC1/MAO-B-IN-1 | Inhibitor | / | Unkown |
| HY-146149 | MAO-B-IN-11 | Inhibitor | / | Unkown |
| HY-146150 | MAO-B-IN-12 | Inhibitor | / | Unkown |
| HY-146312 | AChE/BChE/MAO-B-IN-1 | Inhibitor | 99.57% | Unkown |
| HY-146314 | MAO-B-IN-9 | Inhibitor | 99.70% | Unkown |
| HY-146347 | MAO-B-IN-10 | Inhibitor | / | Unkown |
| HY-146677 | 5-HT6R/MAO-B modulator 1 | / | Unkown | |
| HY-146762 | MAO-B-IN-7 | Inhibitor | / | Unkown |
| HY-147362 | MAO-B-IN-14 | Inhibitor | / | Unkown |
| HY-147953 | MAO-B-IN-13 | Inhibitor | / | Unkown |
| HY-149242 | MAO-B-IN-20 | Inhibitor | / | Unkown |
| HY-149477 | IHC3 | Inhibitor | / | Unkown |
| HY-149527 | MAO-B-IN-23 | Inhibitor | / | Unkown |
| HY-149528 | MAO-B-IN-24 | Inhibitor | / | Unkown |
| HY-149820 | MAO-B-IN-22 | Inhibitor | / | Unkown |
| HY-149978 | LSD1-IN-26 | / | Unkown | |
| HY-149984 | MAO-B-IN-21 | Inhibitor | / | Unkown |
| HY-150563 | Neuroinflammatory-IN-2 | Inhibitor | / | Unkown |
| HY-151094 | FTEAA | Inhibitor | / | Unkown |
| HY-151208 | MAO-B-IN-16 | Inhibitor | / | Unkown |
| HY-151209 | MAO-B-IN-15 | Inhibitor | / | Unkown |
| HY-151210 | MAO-B-IN-17 | Inhibitor | ≥99.0% | Unkown |
| HY-151800 | MAO-A/B-IN-2 | Inhibitor | / | Unkown |
| HY-152109 | AChE/MAO-IN-1 | Inhibitor | / | Unkown |
| HY-152110 | AChE/MAO-IN-2 | Inhibitor | / | Unkown |
| HY-152111 | AChE/MAO-B-IN-3 | Inhibitor | / | Unkown |
| HY-152112 | AChE/BChE/MAO-B-IN-2 | Inhibitor | / | Unkown |
| HY-152113 | AChE/BChE/MAO-B-IN-3 | Inhibitor | / | Unkown |
| HY-152114 | AChE/BChE/MAO-B-IN-4 | Inhibitor | / | Unkown |
| HY-155330 | PZ-1922 | / | Unkown | |
| HY-155330A | PZ-1922 free base | / | Unkown | |
| HY-156348 | MAO-B-IN-26 | Inhibitor | / | Unkown |
| HY-157087 | AChE/MAO-B-IN-4 | Inhibitor | / | Unkown |
| HY-157089 | AChE/MAO-B-IN-5 | Inhibitor | / | Unkown |
| HY-157517 | MAO-B-IN-29 | Inhibitor | / | Unkown |
| HY-157934 | MAO-IN-4 | Inhibitor | / | Unkown |
| HY-157981 | AChE-IN-60 | Inhibitor | / | Unkown |
| HY-157982 | BChE-IN-28 | Inhibitor | / | Unkown |
| HY-158092 | ChEs/MAOs-IN-2 | Inhibitor | / | Unkown |
| HY-158732 | MAO-B-IN-33 | Inhibitor | / | Unkown |
| HY-159106 | MeSeI | / | Unkown | |
| HY-160002 | MAO-B-IN-27 | Inhibitor | / | Unkown |
| HY-161240 | MAO-B-IN-30 | Inhibitor | 98.53% | Unkown |
| HY-162061 | ChEs/MAOs-IN-1 | Inhibitor | / | Unkown |
| HY-162303 | C175-0062 | Inhibitor | / | Unkown |
| HY-162606 | MAO-A/B-IN-3 | Inhibitor | / | Unkown |
| HY-162760 | COMT-IN-1 | Inhibitor | / | Unkown |
| HY-163322 | MAO-A inhibitor 2 | Inhibitor | / | Unkown |
| HY-163380 | CA/MAO-B-IN-1 | Inhibitor | 98.34% | Unkown |
| HY-163474 | MAO-B-IN-32 | Inhibitor | / | Unkown |
| HY-163879 | hMAO-B-IN-9 | Inhibitor | / | Unkown |
| HY-16731 | Sembragiline | Inhibitor | / | Unkown |
| HY-168138 | MAO-B-IN-34 | Inhibitor | / | Unkown |
| HY-168590 | MAO-B-IN-36 | Inhibitor | / | Unkown |
| HY-168728 | MAO-B-IN-37 | Inhibitor | / | Unkown |
| HY-169156 | HDAC6-IN-49 | Inhibitor | / | Unkown |
| HY-170487 | MAO-B-IN-38 | Inhibitor | / | Unkown |
| HY-170798 | Monoamine Oxidase B inhibitor 6 | Inhibitor | / | Unkown |
| HY-170887 | MAO-B-IN-39 | / | Unkown | |
| HY-172101 | AChE/MAO-B-IN-7 | Inhibitor | / | Unkown |
| HY-172460 | AChE/BChE/MAO-B-IN-5 | Inhibitor | / | Unkown |
| HY-172461 | MAO-IN-6 | Inhibitor | / | Unkown |
| HY-173138 | FCOB02 | Ligand | / | Unkown |
| HY-173288 | MAO-B-IN-40 | Inhibitor | / | Unkown |
| HY-173336 | MAO-B-IN-42 | Inhibitor | / | Unkown |
| HY-174419 | TFSeB | / | Unkown | |
| HY-174834 | MAO-B-IN-44 | Inhibitor | / | Unkown |
| HY-175523 | MAO-B-IN-48 | Inhibitor | / | Unkown |
| HY-175524 | BChE/MAO-B-IN-2 | Inhibitor | / | Unkown |
| HY-176245 | Illudinine | Inhibitor | / | Unkown |
| HY-176254 | LSD1-IN-43 | Inhibitor | / | Unkown |
| HY-176271 | MAO-B-IN-45 | / | Unkown | |
| HY-178149 | MAO-A/B-IN-5 | Inhibitor | / | Unkown |
| HY-178352 | MAO-B-IN-49 | / | Unkown | |
| HY-178454 | Multitarget AD-IN-3 | Inhibitor | / | Unkown |
| HY-179126 | BChE/MAO-A-IN-1 | Inhibitor | / | Unkown |
| HY-179167 | K2V-9 | Inhibitor | / | Unkown |
| HY-180114 | NSS-18 | / | Unkown | |
| HY-180842 | MAO-B-IN-50 | Inhibitor | / | Unkown |
| HY-180843 | Aβ/tau aggregation-IN-4 | Inhibitor | / | Unkown |
| HY-181141 | AChE/MAO-B-IN-8 | Inhibitor | / | Unkown |
| HY-181146 | MK-7762 | Inhibitor | / | Unkown |
| HY-181861 | AChE/MAO-B-IN-9 | Inhibitor | / | Unkown |
| HY-181937 | Multi-target kinase-IN-10 | Inhibitor | / | Unkown |
| HY-182481 | MD-230254 | Inhibitor | / | Unkown |
| HY-182786 | MAO-B-IN-56 | Inhibitor | / | Unkown |
| HY-184026 | MAO-B-IN-58 | Inhibitor | / | Unkown |
| HY-D3221 | MAO Probe 1 | / | Unkown | |
| HY-N15470 | MAO-B-IN-52 | Inhibitor | / | Unkown |
| HY-N15657 | Geiparvarin | / | Unkown | |
| HY-N1636 | 1-Methyl-2-nonyl-4(1H)-quinolone | Inhibitor | / | Unkown |
| HY-N1638 | 1-Methyl-2-undecyl-4(1H)-quinolone | Inhibitor | / | Unkown |
| HY-RS08022 | MAOB Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08023 | Maob Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08024 | Maob Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008566S | Norharmane-13C | / | Unkown | |
| HY-W035384 | MAO-B ligand-1 | Inhibitor | / | Unkown |
| HY-W083026 | (E)-CHBO4 | Inhibitor | 97.04% | Unkown |
| HY-W205529 | RO 16-6491 free base | / | Unkown | |
| HY-W269511 | NW-1689 | 99.54% | Unkown | |
| HY-W335927 | MAO-B-IN-19 | Inhibitor | / | Unkown |
| HY-W628136 | MAO-B-IN-47 | Inhibitor | / | Unkown |
| HY-10399B | (S)-Ladostigil | Inhibitor | / | Unkown |
| HY-10400R | Ladostigil hemitartrate (Standard) | Inhibitor | / | Unkown |
| HY-105041 | Tedizolid phosphate sodium | Inhibitor | / | Unkown |
| HY-123556 | SZV-558 | Inhibitor | / | Unkown |
| HY-124885 | MD 220661 | Inhibitor | / | Unkown |
| HY-129444 | MD 780236 free base | Inhibitor | / | Unkown |
| HY-14198S | Selegiline-d5 | Inhibitor | / | Unkown |
| HY-14199S | Selegiline-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-164649 | Atibeprone | Inhibitor | / | Unkown |
| HY-183437 | MAO-B-IN-57 | Inhibitor | / | Unkown |
| HY-19333A | OG-L002 hydrochloride | Inhibitor | / | Unkown |
| HY-70057S4 | Safinamide-d5 | Inhibitor | / | Unkown |
| HY-N12134 | Methyl piperate | Inhibitor | / | Unkown |
| HY-N13041 | Acacetin 7-O-(6-O-malonylglucoside) | Inhibitor | / | Unkown |
| HY-W029600 | 6,7-Dimethylisatin | Inhibitor | / | Unkown |
| HY-W700241 | Norharman-d7 | Inhibitor | / | Unkown |
| HY-W792513 | WAY-620147 | Inhibitor | 98.0% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service